TABLE 2.
Isolate source and group (n)a | Descriptionb |
P value for difference between groupsc |
||||
---|---|---|---|---|---|---|
Group 1 | Group 2 | Group 3 | Group 4 | Group 5d | ||
Fecal | ||||||
Group 0 (38) | Non-ST131, susceptible | 0.30 | <0.001 | <0.001 | <0.001 | 0.55 |
Group 1 (8) | Non-ST131, resistant | 0.008 | <0.001 | 0.006 | 0.92 | |
Group 2 (12) | ST131 | 0.45 | <0.001 | 0.001 | ||
Clinical | ||||||
Group 3 (12) | ST131 | <0.001 | <0.001 | |||
Group 4 (38) | Non-ST131, susceptible | 0.08 |
Fecal, stool isolate from this study; clinical, clinical isolate from 2011 national VA survey (5); n, number of isolates.
Susceptible, susceptible to fluoroquinolones and extended-spectrum cephalosporins (ESCs); resistant, resistant to fluoroquinolones and/or ESCs.
P values were determined by PERMANOVA for pairwise comparisons between isolate groups based on Dice similarity.
Group 5, clinical, non-ST131 resistant isolates (n = 8).